Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Corrigendum to "Continuation phase intravenous ketamine in adults with treatment-resistant depression" [J. Affect. Disord. 206 (2016) 300-304].

Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, Schak KM, Tye SJ, Ritter MJ, Frye MA, Bobo WV.

J Affect Disord. 2017 Sep 26. pii: S0165-0327(17)31955-9. doi: 10.1016/j.jad.2017.09.024. [Epub ahead of print] No abstract available.

PMID:
28967437
2.

Petitioning for Involuntary Commitment for Chemical Dependency by Medical Services.

Lamoureux IC, Schutt PE, Rasmussen KG.

J Am Acad Psychiatry Law. 2017 Sep;45(3):332-338.

PMID:
28939731
3.

Ketamine for the Treatment of Depression.

Rasmussen KG.

JAMA Psychiatry. 2017 Sep 1;74(9):970-971. doi: 10.1001/jamapsychiatry.2017.1773. No abstract available.

PMID:
28700782
4.

The PRIDE Study and the Conduct of Electroconvulsive Therapy: Questions Answered and Unanswered.

Rasmussen KG.

J ECT. 2017 Dec;33(4):225-228. doi: 10.1097/YCT.0000000000000430.

PMID:
28617691
5.

Searching for Optimal Treatment Schedules for Longitudinal ECT.

Rasmussen KG.

Am J Psychiatry. 2017 Apr 1;174(4):397. doi: 10.1176/appi.ajp.2017.16111322. No abstract available.

PMID:
28366090
6.

Continuation phase intravenous ketamine in adults with treatment-resistant depression.

Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, Schak KM, Tye SJ, Ritter MJ, Frye MA, Bobo WV.

J Affect Disord. 2016 Dec;206:300-304. doi: 10.1016/j.jad.2016.09.008. Epub 2016 Sep 12.

PMID:
27656788
7.

Mirtazapine for Symptomatic Relief on a Psychiatric Consultation Service: A Case Series.

Allen ND, Leung JG, Betcher HK, Borreggine KL, Hosker DK, Minton BA, Sukiennik EM, Wilson JJ, Philbrick KL, Rasmussen KG.

Psychosomatics. 2016 Jul-Aug;57(4):409-13. doi: 10.1016/j.psym.2016.02.012. Epub 2016 Mar 2.

PMID:
27095587
8.

Antidepressant medications and the longitudinal course of bipolar disorder revisited.

Rasmussen KG.

J Affect Disord. 2016 Jan 15;190:889-90. No abstract available.

PMID:
27064163
9.

Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment.

Schak KM, Vande Voort JL, Johnson EK, Kung S, Leung JG, Rasmussen KG, Palmer BA, Frye MA.

Am J Psychiatry. 2016 Mar 1;173(3):215-8. doi: 10.1176/appi.ajp.2015.15081082. No abstract available.

PMID:
26926127
10.

An Open-Label, Pilot Study of Daily Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy.

Rasmussen KG, Johnson EK, Kung S, Farrow SL, Brown SK, Govrik MN, Citronowicz RI.

J ECT. 2016 Mar;32(1):33-7. doi: 10.1097/YCT.0000000000000261.

PMID:
26172059
11.

What Type of Cognitive Testing Should Be Part of Routine Electroconvulsive Therapy Practice?

Rasmussen KG.

J ECT. 2016 Mar;32(1):7-12. doi: 10.1097/YCT.0000000000000257. Review.

PMID:
26075697
12.

Thiothixene in the Management of Delirium: A Case Series.

Leung JG, Dare FY, Flowers LM, Murphy LL, Sukiennik EM, Philbrick KL, Rasmussen KG.

Psychosomatics. 2015 Sep-Oct;56(5):542-6. doi: 10.1016/j.psym.2015.02.003. Epub 2015 Feb 16.

PMID:
26002225
13.

Clinical Challenges in Maintenance Electroconvulsive Therapy for Older Patients With Medical Comorbidity.

Sutor B, Rasmussen KG.

J ECT. 2016 Mar;32(1):67-9. doi: 10.1097/YCT.0000000000000248.

PMID:
25993032
14.

Clozapine therapy throughout myelosuppressive chemotherapy: regulations without standardization.

Barreto JN, Leung JG, Philbrick KL, Rasmussen KG, Thompson CA.

Psychooncology. 2015 Nov;24(11):1581-5. doi: 10.1002/pon.3779. Epub 2015 Mar 12. No abstract available.

PMID:
25765766
15.

Recall of paralysis after the seizure with right unilateral ultrabrief technique.

Rasmussen KG.

J ECT. 2015 Jun;31(2):e26. doi: 10.1097/YCT.0000000000000216. No abstract available.

PMID:
25621544
16.

Has psychiatry tamed the "ketamine tiger?" Considerations on its use for depression and anxiety.

Rasmussen KG.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:218-24. doi: 10.1016/j.pnpbp.2015.01.002. Epub 2015 Jan 10. Review.

PMID:
25582770
17.

Ketamine for posttraumatic stress disorder.

Rasmussen KG.

JAMA Psychiatry. 2015 Jan;72(1):94-5. doi: 10.1001/jamapsychiatry.2014.1621. No abstract available.

PMID:
25564790
18.

Lithium for post-electroconvulsive therapy depressive relapse prevention: a consideration of the evidence.

Rasmussen KG.

J ECT. 2015 Jun;31(2):87-90. doi: 10.1097/YCT.0000000000000203. Review.

PMID:
25551481
19.

Court-Approved Electroconvulsive Therapy in Patients Unable to Provide Their Own Consent: A Case Series.

Dare FY, Rasmussen KG.

J ECT. 2015 Sep;31(3):147-9. doi: 10.1097/YCT.0000000000000189.

PMID:
25222527
20.

Rage against the (ECT) machine.

Rasmussen KG.

J ECT. 2015 Mar;31(1):1-2. doi: 10.1097/YCT.0000000000000171. No abstract available.

PMID:
25181022
21.

Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control.

Rasmussen KG.

Acta Neuropsychiatr. 2014 Aug;26(4):230-3. doi: 10.1017/neu.2013.61.

PMID:
25142291
22.
23.

Anesthetic-induced pain on injection in electroconvulsive therapy: review of the literature and suggestions for prevention.

Rasmussen KG, Ritter MJ.

J ECT. 2014 Sep;30(3):203-9. doi: 10.1097/YCT.0000000000000088. Review.

PMID:
24820946
24.

Some considerations of the tolerability of ketamine for ECT anesthesia: a case series and review of the literature.

Rasmussen KG, Ritter MJ.

J ECT. 2014 Dec;30(4):283-6. doi: 10.1097/YCT.0000000000000100. Review.

PMID:
24820945
25.

Propofol for ECT anesthesia a review of the literature.

Rasmussen KG.

J ECT. 2014 Sep;30(3):210-5. doi: 10.1097/YCT.0000000000000093. Review.

PMID:
24820943
26.

A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy.

Rasmussen KG, Kung S, Lapid MI, Oesterle TS, Geske JR, Nuttall GA, Oliver WC, Abenstein JP.

Psychiatry Res. 2014 Feb 28;215(2):362-5. doi: 10.1016/j.psychres.2013.12.027. Epub 2013 Dec 21.

PMID:
24388729
27.

Serial infusions of low-dose ketamine for major depression.

Rasmussen KG, Lineberry TW, Galardy CW, Kung S, Lapid MI, Palmer BA, Ritter MJ, Schak KM, Sola CL, Hanson AJ, Frye MA.

J Psychopharmacol. 2013 May;27(5):444-50. doi: 10.1177/0269881113478283. Epub 2013 Feb 20.

PMID:
23428794
28.

Methohexital-induced seizures during electroconvulsive therapy.

Vande Voort JL, Swintak CC, Wall CA, Rasmussen KG Jr.

J ECT. 2013 Mar;29(1):e4-5. doi: 10.1097/YCT.0b013e3182610596.

PMID:
23422530
29.

Electroconvulsive therapy in the 21st century: same as in the previous century.

Rasmussen KG.

J ECT. 2011 Dec;27(4):338; author reply 338-9. doi: 10.1097/YCT.0b013e3182045be4. No abstract available.

PMID:
22124215
30.

The safety of electroconvulsive therapy in patients with prolonged QTc intervals on the electrocardiogram.

Pullen SJ, Rasmussen KG, Angstman ER, Rivera F, Mueller PS.

J ECT. 2011 Sep;27(3):192-200. doi: 10.1097/YCT.0b013e31821d3911.

PMID:
21681107
31.

Electroconvulsive therapy and melancholia: review of the literature and suggestions for further study.

Rasmussen KG.

J ECT. 2011 Dec;27(4):315-22. doi: 10.1097/YCT.0b013e31820a9482. Review.

PMID:
21673591
32.

Troponin elevations after electroconvulsive therapy: the need for caution.

Martinez MW, Rasmussen KG, Mueller PS, Jaffe AS.

Am J Med. 2011 Mar;124(3):229-34. doi: 10.1016/j.amjmed.2010.09.023.

PMID:
21396506
33.

Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression.

Rasmussen KG.

J ECT. 2011 Mar;27(1):51-4. doi: 10.1097/YCT.0b013e3181da84c6. Review.

PMID:
21343711
34.

Electrical dosing for bitemporal electroconvulsive therapy: what is the best strategy?

Rasmussen KG.

J ECT. 2011 Mar;27(1):91. doi: 10.1097/YCT.0b013e3181da84b4. No abstract available.

PMID:
21336052
35.

Do antidepressants really beget more depressive episodes?

Rasmussen KG.

J Clin Psychiatry. 2011 Jan;72(1):115-6; author reply 116. doi: 10.4088/JCP.10lr06489blu. No abstract available.

PMID:
21272520
36.

Electroconvulsive therapy in palliative care.

Rasmussen KG, Richardson JW.

Am J Hosp Palliat Care. 2011 Aug;28(5):375-7. doi: 10.1177/1049909110390203. Epub 2010 Nov 17.

PMID:
21087947
37.

A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study.

Smith GE, Rasmussen KG Jr, Cullum CM, Felmlee-Devine MD, Petrides G, Rummans TA, Husain MM, Mueller M, Bernstein HJ, Knapp RG, O'Connor MK, Fink M, Sampson S, Bailine SH, Kellner CH; CORE Investigators.

J Clin Psychiatry. 2010 Feb;71(2):185-93. doi: 10.4088/JCP.08m04797gre.

PMID:
20193646
38.

Melancholic symptoms as assessed by the Hamilton Depression Rating Scale and outcomes with and without electroconvulsive therapy on an in-patient mood disorders unit.

Rasmussen KG, Stevens SR, Kung S, Mohan A.

Acta Neuropsychiatr. 2010 Feb;22(1):21-5. doi: 10.1111/j.1601-5215.2009.00425.x.

PMID:
25384953
39.

Au revoir, Association for Convulsive Therapy.

Rasmussen KG, Kellner CH.

J ECT. 2009 Dec;25(4):231. doi: 10.1097/YCT.0b013e3181c18a68. No abstract available.

PMID:
19956015
40.

Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients.

Mueller PS, Albin SM, Barnes RD, Rasmussen KG Jr.

J ECT. 2009 Sep;25(3):165-9. doi: 10.1097/YCT.0b013e31819a61e5.

PMID:
19730028
41.

Serotonin transporter gene status and electroconvulsive therapy outcomes: a retrospective analysis of 83 patients.

Rasmussen KG, Black JL.

J Clin Psychiatry. 2009 Jan;70(1):92-4. Epub 2008 Dec 30.

PMID:
19192461
42.

Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).

Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.

J Clin Psychiatry. 2009 Feb;70(2):232-7. Epub 2009 Jan 13.

PMID:
19192459
43.

4-Fluoro-N-methyl-N-(1,2,3,4-tetra-hydro-carbazol-3-yl)benzene-sulfonamide.

Rasmussen KG, Ulven T, Bond AD.

Acta Crystallogr Sect E Struct Rep Online. 2009 Mar 11;65(Pt 4):o742. doi: 10.1107/S160053680900840X.

44.

Electroconvulsive therapy versus transcranial magnetic stimulation for major depression: a review with recommendations for future research.

Rasmussen KG.

Acta Neuropsychiatr. 2008 Dec;20(6):291-4. doi: 10.1111/j.1601-5215.2008.00333.x.

PMID:
26952060
45.

Is providing 2 seizures at the titration session a good idea?

Rasmussen KG.

J ECT. 2008 Sep;24(3):242. doi: 10.1097/YCT.0b013e3181671af1. No abstract available.

PMID:
18772706
46.

Remifentanil/Thiopental combination and seizure length in electroconvulsive therapy.

Rasmussen KG, Imig MW, Varghese R.

J ECT. 2009 Mar;25(1):31-3. doi: 10.1097/YCT.0b013e3181788270.

PMID:
18665101
47.

Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review.

Hooten WM, Rasmussen KG Jr.

J ECT. 2008 Sep;24(3):208-23. doi: 10.1097/YCT.0b013e31815bfe2a. Review.

PMID:
18628717
49.

Bradycardia and hypotension in a patient with severe aortic stenosis receiving electroconvulsive therapy dose titration for treatment of depression.

Sutor B, Mueller PS, Rasmussen KG.

J ECT. 2008 Dec;24(4):281-2. doi: 10.1097/YCT.0b013e31816dc87e.

PMID:
18580693
50.

Orthostatic hemodynamic changes after electroconvulsive therapy treatments.

Rasmussen KG, Leise AD, Stevens SR.

J ECT. 2008 Jun;24(2):134-6. doi: 10.1097/YCT.0b013e318156dffb.

PMID:
18580557

Supplemental Content

Loading ...
Support Center